INTERSTITIAL LUNG DISEASE
Clinical trials for INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Three-Drug cocktail aims to slow rare lung disease in gene mutation carriers
Disease control Not yet recruitingThis study tests whether a combination of three drugs (prednisone, azithromycin, and hydroxychloroquine) can slow lung function decline in adults with interstitial lung disease caused by surfactant-related gene variants. About 30 participants will receive either the triple therap…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 17, 2026 00:28 UTC
-
Cord blood stem cells take on lung disease in first human test
Disease control Not yet recruitingThis early study tests whether stem cells from donated umbilical cords are safe for people with interstitial lung disease, a condition that scars the lungs and makes breathing hard. About 24 adults will receive an injection of these cells. The main goal is to find the safest dose…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE1 • Sponsor: Shanghai Life Science & Technology • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New hope for lung patients: Long-Term safety trial of inhaled therapy begins
Disease control Not yet recruitingThis study looks at the long-term safety of an inhaled drug called treprostinil palmitil (TPIP) for people with pulmonary hypertension linked to interstitial lung disease. About 344 adults who finished a previous study will take the drug and be monitored for side effects and brea…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Experimental drug targets deadly lung complication in rare autoimmune disease
Disease control Not yet recruitingThis early study tests whether emapalumab, a drug used for a severe immune overreaction, can help people with a rare, rapidly worsening lung disease linked to anti-MDA5 antibodies. The trial will enroll 5 adults whose lung function is declining despite standard care. The main goa…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated May 05, 2026 11:54 UTC
-
New PET probe aims to catch deadly lung scarring earlier
Diagnosis Not yet recruitingThis study tests a special PET scan probe that targets a protein called DDR2, which is found in high levels in scarred lung tissue. The goal is to see if this probe can help doctors diagnose interstitial lung disease (a group of lung scarring conditions) earlier and more accurate…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Diagnosis
Last updated May 13, 2026 16:02 UTC
-
Video games could be the key to easier breathing for lung disease patients
Symptom relief Not yet recruitingThis study will test whether playing active video games as part of a pulmonary rehab program can improve breathing and exercise ability in 42 adults with mild-to-moderate interstitial lung disease. Participants will be split into two groups: one doing video game-based exercises a…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: Istinye University • Aim: Symptom relief
Last updated May 17, 2026 00:40 UTC
-
New smart oxygen device could free lung patients from constant monitoring
Symptom relief Not yet recruitingThis study tests a new device called MoblO2 that automatically adjusts oxygen flow to keep blood oxygen levels steady, so people with COPD or interstitial lung disease don't have to constantly check and adjust their oxygen themselves. About 48 adults who already use oxygen during…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: National Jewish Health • Aim: Symptom relief
Last updated May 17, 2026 00:28 UTC
-
Home workouts may boost heart and lung function in rare disease
Symptom relief Not yet recruitingThis study looks at whether a simple home exercise program can improve daily function in people with pulmonary hypertension caused by interstitial lung disease. About 30 adults will follow a 16-week exercise plan from home. Researchers will measure how efficiently the heart works…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: University of Rochester • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
Can custom oxygen boost daily steps for lung patients?
Symptom relief Not yet recruitingThis study looks at whether portable oxygen therapy, tailored to each person's needs, can help people with interstitial lung disease (ILD) or COPD be more active and feel better in daily life. About 24 adults who only have low oxygen when walking or exercising will try two types …
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: State University of New York at Buffalo • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC